IL18 and Alzheimer disease: Although it remains unclear whether IL-18 plays a role (either primary or secondary) in neurodegeneration-associated cognitive decline, the observed decrease of serum IL-18 after homotaurine supplementation and its significant correlation with clinical parameters sustain the pathogenic importance of IL-18 in AD.